Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasmon-Based Biofilm Inhibition on Surgical Implants.
de Miguel I, Prieto I, Albornoz A, Sanz V, Weis C, Turon P, Quidant R. de Miguel I, et al. Nano Lett. 2019 Apr 10;19(4):2524-2529. doi: 10.1021/acs.nanolett.9b00187. Epub 2019 Mar 18. Nano Lett. 2019. PMID: 30860848
Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia.
Ribera J, Vilches C, Sanz V, de Miguel I, Portolés I, Córdoba-Jover B, Prat E, Nunes V, Jiménez W, Quidant R, Morales-Ruiz M. Ribera J, et al. Among authors: de miguel i. ACS Nano. 2021 Apr 27;15(4):7547-7562. doi: 10.1021/acsnano.1c00988. Epub 2021 Mar 15. ACS Nano. 2021. PMID: 33720693
Long-range optofluidic control with plasmon heating.
Ciraulo B, Garcia-Guirado J, de Miguel I, Ortega Arroyo J, Quidant R. Ciraulo B, et al. Among authors: de miguel i. Nat Commun. 2021 Mar 31;12(1):2001. doi: 10.1038/s41467-021-22280-3. Nat Commun. 2021. PMID: 33790293 Free PMC article.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: de miguel i. Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x. Br J Cancer. 2024. PMID: 38575733 Free PMC article. No abstract available.
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: de miguel i. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. Br J Cancer. 2024. PMID: 38467828 Free PMC article.
50 results